Telix Pharmaceuticals | TLX - Loan Capital

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD551.82M in Loan Capital for its fiscal semester ending in December of 2024.





Loan Capital Change Date
Cochlear AUD 193.5M 10M Jun/2025
CSL USD 10.69B 1.37B Jun/2025
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Mayne Pharma AUD 2.66M 153K Jun/2025
Medical Developments International AUD 1.67M 95K Jun/2025
Mesoblast USD 102.44M 8.18M Jun/2024
Pacific Edge NZD 551K 637K Dec/2025
Paradigm Biopharmaceuticals AUD 100K 79.43K Dec/2024
Polynovo AUD 12.84M 857K Jun/2024
PYC Therapeutics AUD 624.99K 202.1K Jun/2025
Ramsay Health Care AUD 5.46B 5.23B Jun/2025
ResMed USD 403.92M 4.74M Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024